The Business Research Company’s report on the Pediatric Clinical Trials Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
#How have key drivers contributed to the rapid growth of the pediatric clinical trials market?
The rise in pediatric cancer cases is expected to propel the pediatric clinical trials market going forward. Pediatric cancer refers to cancers that develop in children and adolescents under the age of 14. Pediatric cancers are extremely uncommon, and their growth and dissemination patterns may be distinct from those of adult tumors. Pediatric clinical trials continue to play a significant role in the advancement of prognosis and treatment. For instance, in January 2023, according to the American Cancer Society, a US-based voluntary health organization, it is estimated that about 9,910 children in the US under the age of 15 will be diagnosed with cancer and about 1,040 children under the age of 15 are expected to die from cancer in 2023. Therefore, the growing healthcare expenditure is driving the pediatric clinical trials market.
Access Your Free Sample of the Global Pediatric Clinical Trials Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10350&type=smp
How has the pediatric clinical trials market size evolved, and what are the latest forecasts for its expansion?
The pediatric clinical trials market size has grown strongly in recent years. It will grow from$17.41 billion in 2024 to $18.45 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to regulatory incentives, unmet medical needs, advancements in pediatric medicine, global public health initiatives, ethical imperatives, pediatric vaccination programs
The pediatric clinical trials market size is expected to see strong growth in the next few years. It will grow to “$24.8 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to integration of real-world evidence, pediatric biomarker discovery, expanded access programs, pediatric infectious disease research, pediatric cardiology advancements. Major trends in the forecast period include patient-centric trial design, adoption of adaptive trial designs, digital health technologies, global collaboration and consortia, pediatric oncology advancements.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=10350&type=smp
Which major companies dominate the pediatric clinical trials market?
Major companies operating in the pediatric clinical trials market include Medpac Inc., Pharmaceutical Product Development Inc., ICON plc, Syneos Health Inc., QPS Holdings LLC, Pfizer Inc., IQVIA Inc., Premier Research, Labcorp – Laboratory Corporation of America Holdings, The Emmes Company LLC, Synteract Inc., Charles River Laboratories International Inc., Covance Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, BioNTech SE, Moderna Inc., Parexel International Corporation, PRA Health Sciences, Wuxi AppTec, Merck & Co. Inc., AstraZeneca plc, Sanofi S.A., Johnson & Johnson, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, C.H. Boehringer Sohn AG & Co. KG, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Oracle Health sciences
What trends will shape the future of the pd-1 and pdl1 inhibitors/ immune checkpoint inhibitors market?
Product innovation is a key trend gaining popularity in the pediatric clinical trial market. Companies operating in the pediatric clinical trials market are adopting new innovative products to sustain their position in the market. For instance, in June 2022, The Leukemia & Lymphoma Society, a US-based voluntary health organization, launched the Pediatric Acute Leukemia (PedAL) Master Clinical Trial. It is uniquely designed for pediatric acute leukemia where the unique tumor biology of each child’s cancer is identified to help match them with the most promising treatment.
Which region dominates the pediatric clinical trials market, and what factors contribute to its leadership?
North America was the largest region in the pediatric clinical trials market in 2024. The regions covered in the pediatric clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/pediatric-clinical-trials-global-market-report
How is the pediatric clinical trials market segmented, and which segment holds the largest share?
The pediatric clinical trials market covered in this report is segmented –
1) By Phase: Phase I, Phase II, Phase III, Phase IV
2) By Study Design: Treatment Studies, Observational Studies
3) By Therapeutic Areas: Infectious Diseases, Oncology, Autoimmune Or Inflammatory Diseases, Respiratory Disorders, Mental Health Disorders, Other Therapeutic Areas
Subsegments:
1) By Phase I: First-in-Pediatrics Trials, Dose Escalation Studies, Safety And Tolerability Assessments
2) By Phase II: Efficacy Studies, Dose Optimization Trials, Pharmacokinetic Studies
3) By Phase III: Large-Scale Efficacy Trials, Comparative Studies, Long-Term Safety Studies
4) By Phase IV: Post- marketing Surveillance, Long-Term Safety Monitoring, Effectiveness Studies In Real-World Settings
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10350
How is the pediatric clinical trials market defined?
Pediatric clinical trials are trials that investigate the effectiveness, safety, and dosage of pharmaceuticals, medical devices, and other therapies in children. It is essential to develop age-specific, scientifically proven treatments and procedures to identify and improve the best medical therapy possible.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
